CARs on a highway with roadblocks

CARs on a highway with roadblocks

Bibliographic Details
Main Authors:	Lorenzo Galluzzi, Peter Martin
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2017-12-01
Series:	OncoImmunology
Subjects:	acute lymphoblastic leukemia chimeric antigen receptor gene therapy immunotherapy kymriah™ tisagenlecleucel
Online Access:	http://dx.doi.org/10.1080/2162402X.2017.1388486

Similar Items

Characterization of the input material quality for the production of tisagenlecleucel by multiparameter flow cytometry and its relation to the clinical outcome
by: Martin Štach, et al.
Published: (2023-04-01)

Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance
by: Michael M. Boyiadzis, et al.
Published: (2018-12-01)

The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL
by: Forsberg MH, et al.
Published: (2018-09-01)

CAR-T Therapy for T-lineage Leukemia: Progress, Dilemmas, and Way Forward
by: Yajing HAN, et al.
Published: (2024-08-01)

CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia
by: Vairy S, et al.
Published: (2018-11-01)

The treatment of follicular lymphoma with CD19-directed chimeric antigen receptor T-cell therapy
by: Ryan Jacobs, et al.
Published: (2024-06-01)

Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell Malignancies
by: Marika Guercio, et al.
Published: (2021-10-01)

Monitoring of Circulating CAR T Cells: Validation of a Flow Cytometric Assay, Cellular Kinetics, and Phenotype Analysis Following Tisagenlecleucel
by: Andreas Peinelt, et al.
Published: (2022-03-01)

NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful Development
by: Ali Bashiri Dezfouli, et al.
Published: (2021-12-01)

Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD‐19 chimeric antigen receptor T‐cell therapy
by: Francesco Paolo Tambaro, et al.
Published: (2020-09-01)

Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization of Product and Outcomes of Clinical Application
by: Ebru Erdoğan, et al.
Published: (2022-08-01)

Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward
by: Pouya Safarzadeh Kozani, et al.
Published: (2021-10-01)

Clinical Insights on Brexucabtagene Autoleucel for the Treatment of Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
by: Kopmar NE, et al.
Published: (2024-11-01)

Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia
by: Tingting Yang, et al.
Published: (2025-01-01)

First pediatric B-acute lymphoblastic leukemia patient treated with anti-CD19 chimeric antigen receptor T-cell therapy: Long-term remission or early cure?
by: Dimitrios Bouzianas, et al.
Published: (2024-12-01)

The Transferrin Receptor-Directed CAR for the Therapy of Hematologic Malignancies
by: Zilong Guo, et al.
Published: (2021-03-01)

Chimeric Antigen Receptor Based Cellular Therapy for Treatment Of T-Cell Malignancies
by: Kamila Polgárová, et al.
Published: (2022-05-01)

CAR T Cells for Acute Myeloid Leukemia: State of the Art and Future Directions
by: Sherly Mardiana, et al.
Published: (2020-05-01)

Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy
by: Lihong An, et al.
Published: (2022-04-01)

Use of blinatumomab and CAR T-cell therapy in children with relapsed/refractory leukemia: A case series study
by: Songmi Wang, et al.
Published: (2023-01-01)

Tumor Microenvironment Immunosuppression: A Roadblock to CAR T-Cell Advancement in Solid Tumors
by: Abigail Cheever, et al.
Published: (2022-11-01)

CD-19-directed immunotherapy resistance mechanisms of B-precursor acute lymphoblastic leukemia
by: E. V. Glukhanyuk, et al.
Published: (2019-01-01)

CD-19-directed immunotherapy resistance mechanisms of B-precursor acute lymphoblastic leukemia
by: E. V. Glukhanyuk, et al.
Published: (2018-01-01)

Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patients
by: Yunju Ma, et al.
Published: (2023-04-01)

Current Advances in Immunotherapy for Acute Leukemia: An Overview of Antibody, Chimeric Antigen Receptor, Immune Checkpoint, and Natural Killer
by: Yufeng Shang, et al.
Published: (2019-09-01)

Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
by: Mingxue Fan, et al.
Published: (2017-08-01)

Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia
by: Ciprian Tomuleasa, et al.
Published: (2018-02-01)

Beyond CD19: Opportunities for future development of targeted immunotherapy in pediatric relapsed-refractory acute leukemia
by: Haneen eShalabi, et al.
Published: (2015-10-01)

Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia
by: Yue Tan, et al.
Published: (2023-04-01)

Case report: sub-clinical extramedullary B-ALL in the setting of relapse following targeted therapy
by: Claire Johns, et al.
Published: (2024-09-01)

Acute Lymphoblastic Leukemia Relapse Limited to the Anterior Chamber of the Eye and Treated with Novel CAR T-Cell Therapy
by: Nir Gomel, et al.
Published: (2021-12-01)

CAR-T cell therapy for hepatocellular carcinoma: current trends and challenges
by: Yexin Zhou, et al.
Published: (2024-11-01)

Timing of Tocilizumab Administration Under the Guidance of IL-6 in CAR-T Therapy for R/R Acute Lymphoblastic Leukemia
by: Yinqiang Zhang, et al.
Published: (2022-06-01)

Current and Future Perspectives for Chimeric Antigen Receptor T Cells Development in Poland
by: Tomasz J. Ślebioda, et al.
Published: (2022-11-01)

Successful treatment of acute B lymphoblastic leukemia relapse in the skin and testicle by anti-CD19 CAR-T with IL-6 knocking down: a case report
by: Ze-Fa Liu, et al.
Published: (2020-05-01)

Advances in Universal CAR-T Cell Therapy
by: Haolong Lin, et al.
Published: (2021-10-01)

Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions
by: Bachar Samra, et al.
Published: (2020-06-01)

Engineering better chimeric antigen receptor T cells
by: Hao Zhang, et al.
Published: (2020-12-01)

Seatbelts in CAR therapy: How Safe Are CARS?
by: Kentaro Minagawa, et al.
Published: (2015-05-01)

Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanoma
by: Karin Teppert, et al.
Published: (2023-10-01)